Skip to main content
Clinical Trials/NCT06216015
NCT06216015
Completed
N/A

Exercise Training in Kidney Transplant Recipients (EXTRA Trial) Evaluating Physiological and Molecular Outcomes

Hugo de Luca Correa0 sites345 target enrollmentSeptember 30, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Solid Organ Transplant Rejection
Sponsor
Hugo de Luca Correa
Enrollment
345
Primary Endpoint
Functional performance
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

The goal of this clinical trial is to investigate the physiological and molecular effects of exercise training in transplant recipients. The main questions it aims to answer are:

  1. Can exercise training improve physical fitness and muscle strength in transplant recipients?
  2. Can exercise training modulate inflammatory profile, hormones, lipid profile, and exercise-induced molecules in transplant recipients?
  3. Can exercise training improve blood pressure and endothelial health in transplant patients?

Participants will be invited to an exercise training program 6-month after their transplant surgery. Body composition, physical assessment, and blood draw will be assessed at baseline and 24-weeks after exercise or control regimen.

Researchers will compare exercise group vs. routine care group to see if exercise training impact the health-related outcomes of this population.

Detailed Description

The study will involve inviting participants to join an exercise training program six months after their transplant surgery. The research will include baseline assessments and measurements, such as body composition, physical assessment, and blood draws. These assessments will be conducted both at the beginning of the study and 24 weeks after participants have undergone either the exercise regimen or a control regimen. The research team will compare two groups: the exercise group and the routine care group. The goal is to examine whether participating in an exercise training program has a significant impact on various health-related outcomes in transplant recipients when compared to individuals receiving standard care. This clinical trial seeks to understand the potential benefits of exercise training on physical fitness, quality of life, inflammatory and molecular profiles, as well as cardiovascular health in individuals who have undergone organ transplantation. The comparison between the exercise group and the routine care group will provide valuable insights into the effectiveness of exercise interventions for this specific population.

Registry
clinicaltrials.gov
Start Date
September 30, 2015
End Date
December 5, 2023
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Hugo de Luca Correa

Principal Investigator

Catholic University of Brasília

Eligibility Criteria

Inclusion Criteria

  • Medical Authorization:
  • Stable Health Status
  • Medication Consistency
  • No History of Severe Cardiovascular Events
  • No Major Orthopedic Issues
  • Non-Smokers or Consistent Smoking Habits
  • Ability to Comply with Study Protocols

Exclusion Criteria

  • Inability to Comply
  • Cognitive disorders
  • Unwillingness to Continue
  • Unstable Health Conditions
  • Physical limitations during the protocol

Outcomes

Primary Outcomes

Functional performance

Time Frame: Baseline, after 24-weeks and at the end of the protocol

6-minute walking test

Muscle strength

Time Frame: Baseline, after 24-weeks and at the end of the protocol

One Repetition Maximum Test

Isometric muscle strength

Time Frame: Baseline, after 24-weeks and at the end of the protocol

Handgrip strength

Physical fitness

Time Frame: Baseline, after 24-weeks and at the end of the protocol

Ergospirometric Test

Secondary Outcomes

  • Inflammatory profile(Baseline, after 24-weeks and at the end of the protocol)
  • Urea-to-creatinine ratio(Baseline, after 24-weeks and at the end of the protocol)
  • Blood glucose(Baseline, after 24-weeks and at the end of the protocol)
  • Hormones(Baseline, after 24-weeks and at the end of the protocol)
  • Graft rejection(Through study completion, an average of 2 years)

Similar Trials